Luohanguo (Siraitia grosvenorii)

Luohanguo (Siraitia grosvenorii) is a traditional Chinese medicinal fruit containing cucurbitane glycosides that demonstrate antioxidant and hypoglycemic properties. The mogrosides in luohanguo appear to modulate glucose metabolism and provide respiratory tract benefits through anti-inflammatory mechanisms.

Origin & History

Luohanguo (Siraitia grosvenorii) is a perennial vine native to southern China, particularly Guangxi province, cultivated for its round, green-to-brown fruit used as a non-caloric sweetener. The fruit extract is obtained through water extraction, purification using macroporous resins and ion exchange, decolorization, concentration, and drying to yield powdered extracts standardized to 45-60% mogroside V content.

Historical & Cultural Context

In Traditional Chinese Medicine, luohanguo fruit has been used for centuries as a remedy for cough, sore throat, constipation, and as a sweetener, with historical records dating back over 1,000 years in Chinese pharmacopeias. It is categorized as a cooling herb for lung and spleen meridians, promoting phlegm resolution and moistening lungs.

Health Benefits

• May provide antioxidant effects through cucurbitane glycosides (preliminary evidence from pharmacological reviews)
• Potential hypoglycemic properties noted in preclinical studies (human clinical trials lacking)
• Traditional anti-tussive (cough suppressant) effects reported in pharmacological literature (no human RCTs available)
• Possible hepatoprotective activity suggested by constituents (clinical evidence not established)
• Antimicrobial effects attributed to mogrosides in vitro (human studies needed for confirmation)

How It Works

Luohanguo's cucurbitane glycosides, particularly mogrosides IV and V, demonstrate antioxidant activity by scavenging free radicals and inhibiting lipid peroxidation. The hypoglycemic effects appear to involve enhanced glucose uptake and improved insulin sensitivity through AMPK pathway activation. Traditional anti-tussive effects may result from anti-inflammatory actions that reduce respiratory tract irritation.

Scientific Research

The research dossier explicitly states that search results lack specific human clinical trials, RCTs, or meta-analyses with PubMed PMIDs for S. grosvenorii. While preclinical and pharmacological reviews note potential therapeutic effects from mogrosides, the sources emphasize the need for clinical studies to evaluate therapeutic effects, adverse effects, and toxicity in humans.

Clinical Summary

Current evidence for luohanguo primarily comes from preclinical pharmacological studies rather than human clinical trials. Animal studies have shown promising results for blood glucose regulation and antioxidant activity, but specific dosages and effect sizes in humans remain unestablished. Traditional use supports respiratory benefits, though controlled clinical trials are lacking. The evidence base remains preliminary and requires human validation studies.

Nutritional Profile

Luohanguo (Siraitia grosvenorii) dried fruit contains primarily carbohydrates (~73-82% dry weight), with minimal protein (~7-8% dry weight) and negligible fat (<1% dry weight). Crude fiber content approximately 5-7% dry weight. The defining bioactive compounds are cucurbitane-type triterpene glycosides collectively called mogrosides, comprising approximately 1-3% of dried fruit weight: mogroside V (the most abundant, ~0.5-1.0% dry weight, responsible for ~250-300x sweetness relative to sucrose), mogroside IV (~0.1-0.3%), mogroside III (~0.05-0.1%), siamenoside I (trace amounts, ~600x sweeter than sucrose), and 11-oxo-mogroside V (trace). Vitamin C (ascorbic acid) present at approximately 400-500 mg/100g fresh fruit weight, though significantly reduced in dried/processed forms (~50-100 mg/100g dried). Manganese reported at ~1.5-2.0 mg/100g dried weight. Potassium approximately 1100-1300 mg/100g dried weight. Calcium approximately 30-50 mg/100g dried weight. Iron approximately 2-3 mg/100g dried weight. Flavonoids including kaempferol and quercetin glycosides present at trace levels (~0.01-0.05% dry weight). Polysaccharides (glucose- and fructose-based) account for approximately 15-25% dry weight. Bioavailability note: Mogroside V shows limited intestinal absorption in its intact form; gut microbiota metabolize mogrosides into smaller aglycone fragments (mogrol) which may be the primary absorbed species. Commercial mogroside V extracts are standardized to 25-80% mogroside V content. Caloric contribution is negligible in extract form due to non-metabolizable glycoside structure.

Preparation & Dosage

No clinically studied dosage ranges are available as human trials are absent. Commercial extracts are standardized to 45-60% mogroside V content in purified products. FDA GRAS status affirms safety for use as a sweetener but does not specify therapeutic doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, Ginger, Licorice root, Schisandra, Astragalus

Safety & Interactions

Luohanguo is generally recognized as safe for food use with minimal reported adverse effects. No significant drug interactions have been documented, though theoretical concerns exist regarding additive hypoglycemic effects with diabetes medications. Safety during pregnancy and lactation has not been established through clinical studies. Individuals with diabetes should monitor blood glucose when using luohanguo supplements.